Impact of MRD-negative on PFS in myeloma; IPSS-R down-staging before transplant in MDS; hereditary angioedema and venous thromboembolism
This episode of Blood Podcast covers minimal residual disease as a clinical endpoint in multiple myeloma, IPSS-R downstaging before MDS transplant, and the increased risk of venous thromboembolism in hereditary angioedema patients.